Ozempic

FDA Approves Ozempic For Diabetes And Kidney Disease: A Game-Changer For Patients

The US Food and Drug Administration (FDA) has granted approval to Novo Nordisk’s diabetes and weight-loss drug, Ozempic, for patients with both chronic kidney disease (CKD) and diabetes. This decision follows positive clinical trial outcomes demonstrating its effectiveness in reducing kidney failure, disease progression, and cardiovascular-related deaths. The approval is...

Why Stopping Ozempic Can Lead To Weight Gain: Tips For Keeping The Pounds Off

Ozempic (semaglutide) has gained significant attention as an effective weight loss aid, but many individuals are now asking a crucial question: What happens to weight loss once the medication is stopped? While Ozempic has shown promising results during treatment, keeping off the lost weight after discontinuation can be challenging. The...